The Canadian Generic Pharmaceutical Association (CGPA) is launching its “Myth vs. Reality” campaign on LinkedIn and Facebook, aimed at debunking myths about the generic pharmaceutical industry and informing Quebeckers, key industry players and Quebec policymakers about the value of generic prescription medicines.

The generic and biosimilar medicines industries will need to learn more about the Government of Canada’s approach to implementation, and consult with key stakeholders, to help ensure that a transition to this program would maximize the use of cost-saving generic and biosimilar medicines, while protecting Canada’s drug supply and domestic manufacturing capacity.

Michel Robidoux of Sandoz Elected Vice Chair Toronto, February 21, 2024 – The Canadian Generic Pharmaceutical Association (CGPA) is pleased to

Toronto, December 19, 2023 – The Canadian Generic Pharmaceutical Association (CGPA) is pleased to release a new report: “International Pricing

The Canadian Generic Pharmaceutical Association (CGPA) has launched an ad campaign directed at senior executives. With rising costs to employee benefits plans, mandatory generic substitution – a clause built into plans that ensures pharmacists substitute generic medicines in place of expensive brand name drugs – is more important than ever.